SCHEMBL16376121

SCHEMBL16376121

Cc1c(-c2cccc(NC(=O)C(=O)Nc3ccc(-c4ccsc4)cc3)c2)n(C)c2cc(O)c(C(=O)O)cc12

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 20/20 0.83
EPM2A O95278 1/20 0.83
PTPN1 P18031 1/20 0.83
PTPRG P23470 1/20 0.83
ACP1 P24666 1/20 0.83
PTPN3 P26045 1/20 0.83
PTPRM P28827 1/20 0.83
PTPN6 P29350 1/20 0.83
PTPN7 P35236 1/20 0.83
DUSP3 P51452 1/20 0.83
PTPN5 P54829 1/20 0.83
PTPRS Q13332 1/20 0.83
PTPN14 Q15678 1/20 0.83
PTPN21 Q16825 1/20 0.83
UBLCP1 Q8WVY7 1/20 0.83
DUSP23 Q9BVJ7 1/20 0.83
SSU72 Q9NP77 1/20 0.83
CDC14A Q9UNH5 1/20 0.83
PTPN22 Q9Y2R2 1/20 0.83
DUSP10 Q9Y6W6 1/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30366901 0.91 PTPN11 (1.00) PTPN11EPM2APTPN1PTPRGACP1
SCHEMBL16375396 0.91 PTPN11 (1.00) PTPN11EPM2APTPN1PTPRGACP1
SCHEMBL16376118 0.86 PTPN11 (1.00) PTPN11EPM2APTPN1PTPRGACP1
SCHEMBL17669849 0.83 PTPN11 (1.00) PTPN11EPM2APTPN1PTPRGACP1
SCHEMBL16375397 0.81 PTPN11 (1.00) PTPN11EPM2APTPN1PTPRGACP1
SCHEMBL18323176 0.80 PTPN11 (0.91) PTPN11EPM2APTPN1PTPRGACP1
SCHEMBL18323109 0.79 PTPN11 (0.88) PTPN11EPM2APTPN1PTPRGACP1
SCHEMBL18323108 0.78 PTPN11 (0.87) PTPN11EPM2APTPN1PTPRGACP1
SCHEMBL18323118 0.78 PTPN11 (0.89) PTPN11EPM2APTPN1PTPRGACP1
SCHEMBL30367054 0.77 PTPN11 (1.00) PTPN11EPM2APTPN1PTPRGACP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9844535-B2 SHP2 inhibitors and methods of treating autoimmune and/or glomerulonephritis-associated diseases using SHP2 inhibitors INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2017-12-19 US disclosed
WO-2015003094-A2 SHP2 INHIBITORS AND METHODS OF TREATING AUTOIMMUNE AND/OR GLOMERULONEPHRITIS-ASSOCIATED DISEASES USING SHP2 INHIBITORS INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) 2015-01-08 WO disclosed